Business
Rapid Dose Announces Proposed Debt Settlement
Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors") to issue up to an aggregate of 2,500,000 common shares (the "Settlement Shares") to such Creditors in exchange for the cancellation of outstanding accounts payable (the "Shares for Debt Transaction") in the aggregate amount of up to $500,000 (the "Debt") owing to such Creditors. ...
About this update from Rapid Dose Therapeutics Corp
[{"type":"text","content":"Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors") to issue up to an aggregate of 2,500,000 common shares (the "Settlement Shares") to such Creditors in exchange for the cancellation of outstanding accounts payable (the "Shares for Debt Transaction") in the aggregate amount of up to $500,000 (the "Debt") owing to such Creditors. The Settlement Shares will be issued at a price of $0.20, in accordance with the policies of the Canadian Securities Exchange (the "CSE").","length":686,"tagName":"p"},{"type":"text","content":"The Company is completing the Shares for Debt Transaction to improve its financial position by reducing its existing liabilities. All Settlement Shares issued to Canadian residents will be subject to a four-month hold period from the date of issuance. The Shares for Debt Transaction remains subject to CSE acceptance. No new control person of the Company will be created pursuant to the Shares for Debt Transaction.","length":416,"tagName":"p"},{"type":"text","content":"About Rapid Dose Therapeutics Corp. ","length":35,"tagName":"p"},{"type":"text","content":"Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company's flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. For more information about the Company, visit www.rapid-dose.com.","length":479,"tagName":"p"},{"type":"text","content":"Contacts: RDT Investor Contact: Mark Upsdell, CEO [email protected]","length":98,"tagName":"p"},{"type":"text","content":"CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:","length":53,"tagName":"p"},{"type":"text","content":"Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statemen...